nach oben

The International Journal of Cardiovascular Imaging

Erschienen in:

01.04.2013 | Original Paper

Sustained therapeutic perfusion outside transplanted sites in chronic myocardial infarction after stem cell transplantation

verfasst von: Pablo Maureira, Pierre-Yves Marie, Yihua Liu, Fengxu Yu, Sylvain Poussier, Fatiha Maskali, Frederique Groubatch, Gilles Karcher, Nguyen Tran

Erschienen in: The International Journal of Cardiovascular Imaging | Ausgabe 4/2013

Einloggen, um Zugang zu erhalten

Abstract

This study aimed at comparing long-term variations in the perfusion of chronic myocardial infarction (MI) areas after local injections of autologous bone marrow stem cells (BMSCs). 14 coronary ligated rats with transmural chronic MI (4 months) were used: a control group (n = 7) versus a treated group (n = 7) in which ¹¹¹In labeled-BMSCs were directly engrafted on MI areas. By using ¹¹¹In/^99mTc SPECT and Sestamibi gated-SPECT,. left ventricle perfusion and function were monitored in all animals by serial ^99mTc-Sestamibi pinhole gated-SPECT over a period of 6 months. Post-therapeutic myocardial perfusion improved as early as 48 h following injection in the 2 groups. This benefice was sustained during the 6-month follow-up in the non-engrafted MI-areas from treated rats (at 6-months: +10 ± 5 %), whereas the engrafted ones, as well as the MI areas from control rats, exhibited progressive deterioration over time (at 6-months: −9 ± 10 % and −5 ± 3 %, respectively). Perfusion enhancement of the chronic MI areas treated by BMSCs transplantation is: (1) marked in the following days, presumably because of an unspecific inflammatory reaction, and (2) sustained over the long term but only outside the sites of cell engraftment, suggesting a distant paracrine effect of transplanted cells.

Maskali F, Franken PR, Poussier S, Tran N, Vanhove C, Boutley H, Le Gall H, Karcher G, Zannad F, Lacolley P, Marie PY (2006) Initial infarct size predicts subsequent cardiac remodeling in the rat infarct model: an in vivo serial pinhole gated SPECT study. J Nucl Med 47:337–344PubMed

Caplan AI, Dennis JE (2006) Mesenchymal stem cells as trophic mediators. J Cell Biochem 98:1076–1084PubMedCrossRef

Dai W, Hale SL, Kloner RA (2007) Role of a paracrine action of mesenchymal stem cells in the improvement of left ventricular function after coronary artery occlusion in rats. Regen Med 2:63–68PubMedCrossRef

Duffy GP, Ahsan T, O’Brien T, Barry F, Nerem R (2009) Bone marrow derived mesenchymal stem cells promote angiogenic processes in a time and dose dependent manner in vitro. Tissue Eng Part A 15:2459–2470PubMedCrossRef

Beeres SL, Bax JJ, Dibbets-Schneider P, Stokkel MP, Fibbe WE, Van der Wall EE, Schalij MJ, Atsma DE (2007) Intramyocardial injection of autologous bone marrow mononuclear cells in patients with chronic myocardial infarction and severe left ventricular dysfunction. Am J Cardiol 100:1094–1098PubMedCrossRef

Kim BO, Tian H, Prasongsukarn K, Wu J, Angoulvant D, Wnendt S, Muhs A, Spitkovsky D, Li RK (2005) Cell transplantation improves ventricular function after a myocardial infarction: a preclinical study of human unrestricted somatic stem cells in a porcine model. Circulation 112:I96–I104PubMedCrossRef

Tran N, Franken PR, Maskali F, Nloga J, Maureira P, Poussier S, Groubatch F, Vanhove C, Villemot JP, Marie PY (2007) Intramyocardial Implantation of bone marrow-derived stem cells enhances perfusion in chronic myocardial infarction: dependency on initial perfusion depth and follow-up assessed by gated pinhole SPECT. J Nucl Med 48:405–412PubMed

Gao F, He T, Wang H, Yu S, Yi D, Liu W, Cai Z (2007) A promising strategy for the treatment of ischemic heart disease: mesenchymal stem cell-mediated vascular endothelial growth factor gene transfer in rats. Can J Cardiol 23:891–898PubMedCrossRef

Tang YL, Zhao Q, Qin X, Shen L, Cheng L, Ge J, Phillips MI (2005) Paracrine action enhances the effects of autologous mesenchymal stem cell transplantation on vascular regeneration in rat model of myocardial infarction. Ann Thorac Surg 80(1):229–236PubMedCrossRef

10.

Tang YL, Zhao Q, Zhang YC, Cheng L, Liu M, Shi J, Yang YZ, Pan C, Ge J, Phillips MI (2004) Autologous mesenchymal stem cell transplantation induce VEGF and neovascularization in ischemic myocardium. Regul Pept 117:3–10PubMedCrossRef

11.

Hu X, Wang J, Chen J, Luo R, He A, Xie X, Li J (2007) Optimal temporal delivery of bone marrow mesenchymal stem cells in rats with myocardial infarction. Eur J Cardiothorac Surg 31:438–443PubMedCrossRef

12.

Tran N, Poussier S, Franken PR, Maskali F, Groubatch F, Vanhove C, Antunes L, Karcher G, Villemot JP, Marie PY (2006) Feasibility of in vivo dual-energy myocardial SPECT for monitoring the distribution of transplanted cells in relation to the infarction site. Eur J Nucl Med Mol Imaging 33:709–715PubMedCrossRef

13.

Tran N, Li Y, Maskali F, Antunes L, Maureira P, Laurens MH, Marie PY, Karcher G, Groubatch F, Stoltz JF, Villemot JP (2006) Short-term heart retention and distribution of intramyocardial delivered mesenchymal cells within necrotic or intact myocardium. Cell Transplant 15:351–358PubMedCrossRef

14.

Marie PY, Djaballah W, Franken PR, Vanhove C, Muller MA, Boutley H, Poussier S, Olivier P, Karcher G, Bertrand A (2005) OSEM reconstruction, associated with temporal fourier and depth-dependant resolution recovery filtering, enhances results from sestamibi and 201Tl 16-interval gated SPECT. J Nucl Med 46:1789–1795PubMed

15.

Vanhove C, Andreyev A, Defrise M, Nuyts J, Bossuyt A (2007) Resolution recovery in pinhole SPECT based on multi-ray projections: a phantom study. Eur J Nucl Med Mol Imaging 34:170–180PubMedCrossRef

16.

Vanhove C, Franken PR, Defrise M, Deconinck F, Bossuyt A (2002) Reconstruction of gated myocardial perfusion SPET incorporating temporal information during iterative reconstruction. Eur J Nucl Med Mol Imaging 29:465–472PubMedCrossRef

17.

Lauer B, Junghans U, Stahl F, Kluge R, Oesterle SN, Schuler G (1999) Catheter-based percutaneous myocardial laser revascularization in patients with end-stage coronary artery disease. J Am Coll Cardiol 34:1663–1670PubMedCrossRef

18.

Van Huyen JP, Smadja DM, Bruneval P, Gaussem P, Dal-Cortivo L, Julia P, Fiessinger JN, Cavazzana-Calvo M, Aiach M, Emmerich J (2008) Bone marrow-derived mononuclear cell therapy induces distal angiogenesis after local injection in critical leg ischemia. Mod Pathol 21:837–846CrossRef

19.

Belanger AJ, Lu H, Date T, Liu L, Vincent KA, Akita GY, Cheng SH, Gregory RJ, Jiang C (2002) Hypoxia up-regulates expression of peroxisome proliferator-activated receptor gamma angiopoietin-related gene (PGAR) in cardiomyocytes: role of hypoxia inducible factor 1alpha. J Mol Cell Cardiol 34:765–774PubMedCrossRef

20.

Wu G, Mannam AP, Wu J, Kirbis S, Shie JL, Chen C, Laham RJ, Sellke F, Li J (2003) Hypoxia induces myocyte-dependent COX-2 regulation in endothelial cells: role of VEGF. Am J Physiol Heart Circ Physiol 285:H2420–H2429PubMed

21.

Feygin J, Mansoor A, Eckman P, Swingen C, Zhang J (2007) Functional and bioenergetic modulations in the infarct border zone following autologous mesenchymal stem cell transplantation. Am J Physiol Heart Circ Physiol 293:H1772–H1780PubMedCrossRef

22.

Haider H, Jiang S, Idris NM, Ashraf M (2008) IGF-1-overexpressing mesenchymal stem cells accelerate bone marrow stem cell mobilization via paracrine activation of SDF-1alpha/CXCR4 signaling to promote myocardial repair. Circ Res 103:1300–1308PubMedCrossRef

23.

Li L, Zhang S, Zhang Y, Yu B, Xu Y, Guan Z (2009) Paracrine action mediate the antifibrotic effect of transplanted mesenchymal stem cells in a rat model of global heart failure. Mol Biol Rep 36:725–731PubMedCrossRef

24.

Li L, Zhang Y, Li Y, Yu B, Xu Y, Zhao S, Guan Z (2008) Mesenchymal stem cell transplantation attenuates cardiac fibrosis associated with isoproterenol-induced global heart failure. Transpl Int 21:1181–1189PubMedCrossRef

25.

Lee BC, Hsu HC, Tseng WY, Chen CY, Lin HJ, Ho YL, Su MJ, Chen MF (2009) Cell therapy generates a favourable chemokine gradient for stem cell recruitment into the infarcted heart in rabbits. Eur J Heart Fail 11:238–245PubMedCrossRef

26.

Unzek S, Zhang M, Mal N, Mills WR, Laurita KR, Penn MS (2007) SDF-1 recruits cardiac stem cell-like cells that depolarize in vivo. Cell Transplant 16:879–886PubMedCrossRef

27.

Zhang M, Mal N, Kiedrowski M, Chacko M, Askari AT, Popovic ZB, Koc ON, Penn MS (2007) SDF-1 expression by mesenchymal stem cells results in trophic support of cardiac myocytes after myocardial infarction. Faseb J 21:3197–3207PubMedCrossRef

28.

Dai W, Hale SL, Martin BJ, Kuang JQ, Dow JS, Wold LE, Kloner RA (2005) Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: short- and long-term effects. Circulation 112:214–223PubMedCrossRef

29.

Hashemi SM, Ghods S, Kolodgie FD, Parcham-Azad K, Keane M, Hamamdzic D, Young R, Rippy MK, Virmani R, Litt H, Wilensky RL (2008) A placebo controlled, dose-ranging, safety study of allogenic mesenchymal stem cells injected by endomyocardial delivery after an acute myocardial infarction. Eur Heart J 29:251–259PubMedCrossRef

30.

Li W, Ma N, Ong LL, Nesselmann C, Klopsch C, Ladilov Y, Furlani D, Piechaczek C, Moebius JM, Lutzow K, Lendlein A, Stamm C, Li RK, Steinhoff G (2007) Bcl-2 engineered MSCs inhibited apoptosis and improved heart function. Stem Cells 25:2118–2127PubMedCrossRef

31.

Lee J, Stagg MA, Fukushima S, Soppa GK, Siedlecka U, Youssef SJ, Suzuki K, Yacoub MH, Terracciano CM (2009) Adult progenitor cell transplantation influences contractile performance and calcium handling of recipient cardiomyocytes. Am J Physiol Heart Circ Physiol 296:H927–H936PubMedCrossRef

32.

Markel TA, Wang Y, Herrmann JL, Crisostomo PR, Wang M, Novotny NM, Herring CM, Tan J, Lahm T, Meldrum DR (2008) VEGF is critical for stem cell-mediated cardioprotection and a crucial paracrine factor for defining the age threshold in adult and neonatal stem cell function. Am J Physiol Heart Circ Physiol 295:H2308–H2314PubMedCrossRef

33.

Zeng L, Hu Q, Wang X, Mansoor A, Lee J, Feygin J, Zhang G, Suntharalingam P, Boozer S, Mhashilkar A, Panetta CJ, Swingen C, Deans R, From AH, Bache RJ, Verfaillie CM, Zhang J (2007) Bioenergetic and functional consequences of bone marrow-derived multipotent progenitor cell transplantation in hearts with postinfarction left ventricular remodeling. Circulation 115:1866–1875PubMedCrossRef

34.

Suzuki K, Murtuza B, Beauchamp JR, Brand NJ, Barton PJ, Varela-Carver A, Fukushima S, Coppen SR, Partridge TA, Yacoub MH (2004) Role of interleukin-1beta in acute inflammation and graft death after cell transplantation to the heart. Circulation 110:219–224

35.

Maureira P, Tran N, Djaballah W, Angioï M, Bensoussan D, Didot N, Fay R, Sadoul N, Villemot JP, Marie PY (2012) Residual viability is a predictor of the perfusion enhancement obtained with the cell therapy of chronic myocardial infarction: a pilot multimodal imaging study. Clin Nucl Med 37(8):738–742PubMedCrossRef

Titel: Sustained therapeutic perfusion outside transplanted sites in chronic myocardial infarction after stem cell transplantation
verfasst von: Pablo Maureira
Pierre-Yves Marie
Yihua Liu
Fengxu Yu
Sylvain Poussier
Fatiha Maskali
Frederique Groubatch
Gilles Karcher
Nguyen Tran
Publikationsdatum: 01.04.2013
Verlag: Springer Netherlands
Erschienen in: The International Journal of Cardiovascular Imaging / Ausgabe 4/2013
Print ISSN: 1569-5794
Elektronische ISSN: 1875-8312
DOI: https://doi.org/10.1007/s10554-012-0147-9

Neu im Fachgebiet Kardiologie

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2013

Impact of transmural necrosis on left ventricular remodeling and clinical outcomes in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction

Mapping contrast agent uptake and retention in MRI studies of myocardial perfusion: case control study of dogs with Duchenne muscular dystrophy

Multimodality noninvasive cardiac imaging established the diagnosis of aneurysms of Vieussens’ arterial ring

High-sensitivity troponin T and C-reactive protein to identify patients without cardiac structural and functional abnormalities as assessed by cardiac CT and SPECT imaging: can biomarkers predict cardiac health?